Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Liposome Drug Delivery market was valued at 2768 Million US$ in 2018 and is projected to reach 5985 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 10.12% during the forecast period.
This report presents the market size and development trends by detailing the Liposome Drug Delivery market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Liposome Drug Delivery market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Liposome Drug Delivery industry and will help you to build a panoramic view of the industrial development.
Liposome Drug Delivery Market, By Type:
Liposomal doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Others
Liposome Drug Delivery Market, By Application:
Fungal Infection Therapy
Cancer Therapy ( Tumor therapy)
Others
Some of the leading players are as follows:
Crucell
Novartis
Johnson & Johnson
Kingond Pharm
Fudan-Zhangjiang
Gilead Sciences
Sun Pharmaceutical
Sigma-Tau Group
Luye Pharma
Teva Pharmaceutical
Shanghai New Asia
Spectrum Pharmaceuticals
CSPC
Celsion Corporation
Pacira
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Liposome Drug Delivery Market: Technology Type Analysis
-
4.1 Liposome Drug Delivery Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Liposome Drug Delivery Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Liposomal doxorubicin
4.3.2 Liposomal Amphoteracin B
4.3.3 Liposomal Paclitaxel
4.3.4 Others
5 Liposome Drug Delivery Market: Product Analysis
-
5.1 Liposome Drug Delivery Product Market Share Analysis, 2018 & 2026
-
5.2 Liposome Drug Delivery Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Liposome Drug Delivery Market: Application Analysis
-
6.1 Liposome Drug Delivery Application Market Share Analysis, 2018 & 2026
-
6.2 Liposome Drug Delivery Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Fungal Infection Therapy
6.3.2 Cancer Therapy ( Tumor therapy)
6.3.3 Others
7 Liposome Drug Delivery Market: Regional Analysis
-
7.1 Liposome Drug Delivery Regional Market Share Analysis, 2018 & 2026
-
7.2 Liposome Drug Delivery Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Crucell
9.1.1 Crucell Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Novartis
9.2.1 Novartis Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Johnson & Johnson
9.3.1 Johnson & Johnson Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Kingond Pharm
9.4.1 Kingond Pharm Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Fudan-Zhangjiang
9.5.1 Fudan-Zhangjiang Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Gilead Sciences
9.6.1 Gilead Sciences Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Sun Pharmaceutical
9.7.1 Sun Pharmaceutical Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Sigma-Tau Group
9.8.1 Sigma-Tau Group Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Luye Pharma
9.9.1 Luye Pharma Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Teva Pharmaceutical
9.10.1 Teva Pharmaceutical Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
9.11 Shanghai New Asia
9.11.1 Shanghai New Asia Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis
9.12 Spectrum Pharmaceuticals
9.12.1 Spectrum Pharmaceuticals Company overview
9.12.2 Financial performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives
9.12.5 SWOT analysis
9.13 CSPC
9.13.1 CSPC Company overview
9.13.2 Financial performance
9.13.3 Product benchmarking
9.13.4 Strategic initiatives
9.13.5 SWOT analysis
9.14 Celsion Corporation
9.14.1 Celsion Corporation Company overview
9.14.2 Financial performance
9.14.3 Product benchmarking
9.14.4 Strategic initiatives
9.14.5 SWOT analysis
9.15 Pacira
9.15.1 Pacira Company overview
9.15.2 Financial performance
9.15.3 Product benchmarking
9.15.4 Strategic initiatives
9.15.5 SWOT analysis
The List of Tables and Figures (Totals 101 Figures and 121 Tables)
Figure Liposomal doxorubicin Liposome Drug Delivery market, 2015 - 2026 (USD Million)
Figure Liposomal Amphoteracin B Liposome Drug Delivery market, 2015 - 2026 (USD Million)
Figure Liposomal Paclitaxel Liposome Drug Delivery market, 2015 - 2026 (USD Million)
Figure Others Liposome Drug Delivery market, 2015 - 2026 (USD Million)
Figure Fungal Infection Therapy market, 2015 - 2026 (USD Million)
Figure Cancer Therapy ( Tumor therapy) market, 2015 - 2026 (USD Million)
Figure Others market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Liposome Drug Delivery market, by country, 2015 - 2026 (USD Million)
-
Table North America Liposome Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table North America Liposome Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table North America Liposome Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Liposome Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Liposome Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Liposome Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Liposome Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table Canada Liposome Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table Canada Liposome Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Europe Liposome Drug Delivery market, by country, 2015 - 2026 (USD Million)
-
Table Europe Liposome Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table Europe Liposome Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table Europe Liposome Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Liposome Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Liposome Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Liposome Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Liposome Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table Germany Liposome Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table Germany Liposome Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Liposome Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table France Liposome Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table France Liposome Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Liposome Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table Italy Liposome Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table Italy Liposome Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Liposome Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table Spain Liposome Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table Spain Liposome Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Liposome Drug Delivery market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Liposome Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Liposome Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Liposome Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Liposome Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table China Liposome Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table China Liposome Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Liposome Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table Japan Liposome Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table Japan Liposome Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Liposome Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table India Liposome Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table India Liposome Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Liposome Drug Delivery market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Liposome Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Liposome Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Liposome Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Liposome Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Liposome Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Liposome Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Liposome Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Liposome Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Liposome Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Liposome Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Liposome Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Liposome Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table MEA Liposome Drug Delivery market, by country, 2015 - 2026 (USD Million)
-
Table MEA Liposome Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table MEA Liposome Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table MEA Liposome Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Liposome Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Liposome Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Liposome Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Liposome Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Liposome Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Liposome Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Crucell Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Novartis Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Johnson & Johnson Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Kingond Pharm Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Fudan-Zhangjiang Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Gilead Sciences Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Sun Pharmaceutical Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Sigma-Tau Group Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Luye Pharma Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Teva Pharmaceutical Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Shanghai New Asia Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Spectrum Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table CSPC Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Celsion Corporation Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Pacira Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
